TTFields

August 3, 2018

Adding TTFields to Taxol May Help Recurrent Ovarian Cancer Patients, Study Shows

News

Adding Tumor Treating Fields (TTFields) — a therapy that uses electric fields to induce cell death — to weekly Taxol (paclitaxel) more than doubles the time to disease worsening or death in ovarian cancer patients ... Read more

May 30, 2018January 9, 2019

Phase 3 Trial to Assess TTFields plus Taxol in Platinum-resistant Ovarian Cancer Patients

News

A Phase 3 clinical trial will investigate the impact of adding Tumor Treating Fields (TTFields), a method that uses electric fields to disrupt cell division, to Taxol (paclitaxel) for the treatment of ... Read more

April 10, 2017

TTFields, Taxol Combo Shows Promise in Recurrent Ovarian Cancer Patients

News

Patients with recurrent ovarian cancer may greatly benefit from the addition of Tumor Treating Fields (TTFields), a method that uses electric fields to disrupt cell division, to Taxol (paclitaxel), according to ... Read more

December 21, 2016

Phase 2 Trial Suggests TTFields-Chemotherapy Combo May Improve Outcomes in Recurrent Ovarian Cancer

News

Combining Tumor Treating Fields (TTFields), a method that uses electric fields to disrupt cell division, with Taxol (paclitaxel) may be a promising treatment approach for ovarian cancer patients, according to recent ... Read more